Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 5 clinical trials
Cabergoline as a Preventive Treatment for Chronic Migraine

models and a study of prolactine-associated headaches have indicated that dopamine agonists such as cabergoline might be used as a treatment of migraine. The aim of this study is to test the

chronic migraine
headache
  • 0 views
  • 07 Oct, 2022
  • 1 location
Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma

The aim of this study is to investigate whether inhibition of serum prolactin levels below normal range during cabergoline administration may reduce the recurrence rate after drug withdrawal in

prolactinoma
prolactin
drug withdrawal
cabergoline
  • 90 views
  • 27 Feb, 2022
  • 1 location
Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas

induce tumour shrinkage. At present, cabergoline is the dopamine agonist most widely used in the treatment of pituitary adenomas secreting prolactin. Aim is to study the effect of medical

pituitary adenoma
cabergoline
pituitary disorders
hypopituitarism
prolactin
  • 65 views
  • 12 Sep, 2021
  • 3 locations
Novel, Non-Hormonal Therapy for the Treatment of Chronic Pain Due to Endometriosis in Adolescent and Adult Women

agents inappropriate for use in reproductive-age patients. This obstacle will be overcome by performing a randomized, double blind clinical trial aimed at repurposing an existing drug, cabergoline, as a

  • 18 views
  • 11 Oct, 2022
  • 1 location
Factors and Outcomes Associated With Postpartum Cabergoline Use

Cabergoline is frequently being requested by many postpartum women with a live newborn to suppress lactation. The aim of the study is to investigate which women desire such an intervention, and

Accepts healthy volunteers
  • 30 views
  • 09 Feb, 2022
  • 1 location